HOME > Investors > Press Releases
2008-03-04
ViroMed announces the launch of a joint study with Biologics Delivery Systems of Cordis Corporation, a Johnson & Johnson Company
2007-08-09
ViroMed Completes First Cohort of Patients in Novel Cardiovascular Gene Therapy
2007-02-13
Announced interim unaudited results for the year ending December 31, 2006
2007-01-19
Korean FDA approves Phase I/II clinical trial for VM106
2007-01-19
US FDA approves Phase I clinical trial for VM202
21 22 23 24 25 26